Cargando…

Regulation of Fatty Acid Metabolism and Inhibition of Colorectal Cancer Progression by Erchen Decoction

Erchen decoction (ECD) is a traditional Chinese prescription widely used in the treatment of various diseases such as obesity, fatty liver, diabetes, and hypertension. In this study, we investigated the effect of ECD on fatty acid metabolism in a colorectal cancer (CRC) mouse model fed a high-fat (H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Linghong, Zhang, Fei, Zhuo, Zewei, Huang, Chengbao, Zhang, Xiaofang, Liu, Ruifang, Gao, Bizhen, Ding, Shanshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110375/ https://www.ncbi.nlm.nih.gov/pubmed/37078067 http://dx.doi.org/10.1155/2023/9557720

Ejemplares similares

Erchen Decoction Ameliorates Lipid Metabolism by the Regulation of the Protein CAV-1 and the Receptors VLDLR, LDLR, ABCA1, and SRB1 in a High-Fat Diet Rat Model
por: Ding, Shanshan, et al.
Publicado: (2018)

Investigating the effects and mechanisms of Erchen Decoction in the treatment of colorectal cancer by network pharmacology and experimental validation
por: Shao, Yanfei, et al.
Publicado: (2022)

Erchen Decoction Mitigates Lipid Metabolism Disorder by the Regulation of PPARγ and LPL Gene in a High-Fat Diet C57BL/6 Mice Model
por: Zhang, Mengting, et al.
Publicado: (2020)

The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats
por: Zhao, Tian, et al.
Publicado: (2021)

Erchen Decoction Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats
por: Cheng, Ya, et al.
Publicado: (2022)

Erchen Decoction Prevents High-Fat Diet Induced Metabolic Disorders in C57BL/6 Mice
por: Gao, Bi-Zhen, et al.
Publicado: (2015)

Retracted: Erchen Decoction Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Erchen decoction for hyperlipemia: Protocol for a systematic review and meta-analysis
por: Luo, Huan, et al.
Publicado: (2020)

Erchen decoction combined with Sanziyangqin decoction for chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Deng, Lu, et al.
Publicado: (2020)

Exploring the mechanism of Erchen decoction in the treatment of atherosclerosis based on network pharmacology and molecular docking
por: Li, Wenwen, et al.
Publicado: (2023)

Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro
por: Zhang, Huicun, et al.
Publicado: (2017)

Herb-symptom analysis of Erchen decoction combined with Xiebai powder formula and its mechanism in the treatment of chronic obstructive pulmonary disease
por: Ye, Hua, et al.
Publicado: (2023)

An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway
por: Xie, Tian-hong, et al.
Publicado: (2017)

Retracted: An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2019)

Erchen Plus Huiyanzhuyu Decoction Inhibits the Growth of Laryngeal Carcinoma in a Mouse Model of Phlegm-Coagulation-Blood-Stasis Syndrome via the STAT3/Cyclin D1 Pathway
por: Tan, Xi, et al.
Publicado: (2020)

Effects of Erchen Decoction on Oxidative Stress-Related Cytochrome P450 Metabolites of Arachidonic Acid in Dyslipidemic Mice with Phlegm-Dampness Retention Syndrome: A Randomized, Controlled Trial on the Correspondence between Prescription and Syndrome
por: Chen, Jing, et al.
Publicado: (2022)

Pingmu Decoction Induces Orbital Preadipocytes Apoptosis In Vitro
por: Zhang, Yali, et al.
Publicado: (2017)

Observing the development of the temporomandibular joint in embryonic and post-natal mice using various staining methods
por: LIANG, WENNA, et al.
Publicado: (2016)

Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease
por: Yang, Fuyuan, et al.
Publicado: (2022)

Identification of shared fatty acid metabolism related signatures in dilated cardiomyopathy and myocardial infarction
por: Huang, Baoyi, et al.
Publicado: (2023)

Erratum to “Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease”
por: Yang, Fuyuan, et al.
Publicado: (2022)

LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism
por: Wu, Yupeng, et al.
Publicado: (2021)

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022)

Geijigajakyak decoction inhibits the motility and tumorigenesis of colorectal cancer cells
por: Lee, Soong-in, et al.
Publicado: (2016)

Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease
por: Liu, Tao, et al.
Publicado: (2013)

Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
por: Yang, Jiayao, et al.
Publicado: (2020)

Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
por: Yan, Bao-Fei, et al.
Publicado: (2023)

Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism
por: Cui, Huantian, et al.
Publicado: (2020)

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
por: Wei, Wei, et al.
Publicado: (2023)

Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota
por: Liao, Jiabao, et al.
Publicado: (2021)

Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy
por: Ding, Chengsheng, et al.
Publicado: (2021)

Sini Decoction Ameliorates Colorectal Cancer and Modulates the Composition of Gut Microbiota in Mice
por: Wang, Yishan, et al.
Publicado: (2021)

Wendan decoction in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis
por: Zhang, Yufeng, et al.
Publicado: (2022)

Effects of Qutanhuoxue Decoction on AQP7 and AQP9 Expression in Nonalcoholic Fatty Liver Model Rats
por: Zheng, Ding, et al.
Publicado: (2019)

Multiple mitochondria-targeted components screened from Sini decoction improved cardiac energetics and mitochondrial dysfunction to attenuate doxorubicin-induced cardiomyopathy
por: Ding, Xin, et al.
Publicado: (2023)

Integrated Network Pharmacology and Clinical Study to Reveal the Effects and Mechanisms of Bushen Huoxue Huatan Decoction on Polycystic Ovary Syndrome
por: Ding, Jie, et al.
Publicado: (2022)

Gegen Qinlian Decoction Treats Diarrhea in Piglets by Modulating Gut Microbiota and Short-Chain Fatty Acids
por: Liu, Chang-Shun, et al.
Publicado: (2019)

Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling
por: Yang, Jiayao, et al.
Publicado: (2022)

Pi-Dan-Jian-Qing Decoction Ameliorates Type 2 Diabetes Mellitus Through Regulating the Gut Microbiota and Serum Metabolism
por: Xie, Xuehua, et al.
Publicado: (2021)

PKM2 Is the Target of a Multi-Herb-Combined Decoction During the Inhibition of Gastric Cancer Progression
por: Sun, Qingmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kuj0iq022u6voveem8b9g84kag